Related by context. All words. (Click for frequent words.) 66 analyst Sapna Srivastava 65 analyst Jim Birchenough 65 analyst Randall Stanicky 64 analyst Yaron Werber 64 Geoffrey Meacham 63 Steven Harr 63 Joel Sendek 63 Eric Ende 63 analyst Geoffrey Meacham 63 analyst Jim Reddoch 62 Dr. Jim Birchenough 62 Roopesh Patel 62 Akhtar Samad 62 Geoff Meacham 61 analyst Thilo Wrede 61 Yaron Werber 61 Jim Birchenough 61 analyst Alexandra Hauber 61 Bret Holley 61 Dr. Yaron Werber 61 analyst Jami Rubin 61 Geoff Porges 60 analyst Cory Kasimov 59 analyst Lawrence Keusch 59 Joshua Schimmer 59 Chris Shibutani 59 See BioWorld Today 59 Jim Reddoch 58 analyst Mark Schoenebaum 58 Alexandra Hauber 58 Gbola Amusa 58 analyst Rebecca Runkle 58 Jason Kantor 58 Liisa Bayko 57 Inc. NASDAQ ITMN 57 analyst George Grofik 57 analyst Maged Shenouda 57 analyst Mark Monane 57 analyst Bruce Nudell 57 analyst Jonathan Aschoff 57 reaffirmed Outperform rating 57 David Amsellem 56 analyst Geoffrey Porges 56 Ken Cacciatore 56 Liana Moussatos 56 Margaret Mager 56 Cory Kasimov 56 economist Tetsufumi Yamakawa 56 Sam Fazeli 56 Securities Ld EPT 56 economist Tushar Poddar 56 David Molowa 55 analyst Ken Trbovich 55 analyst Aldo Mazzaferro 55 blood thinner prasugrel 55 Inc. NASDAQ TRMS 55 Geoffrey Porges 55 Merck KGaA Erbitux 55 RAPTIVA r 55 FDA approvable letter 55 Matthew Borsch 55 analyst Gbola Amusa 55 Bloomberg GlaxoSmithKline Plc 55 Jami Rubin 55 Ian Somaiya 55 Canaccord Adams Hepatitis C 55 analyst Seamus Fernandez 55 analyst Gurinder Kalra 55 Piper Jaffray PJC 55 Bloomberg AstraZeneca Plc 54 Onyx Pharma 54 NASDAQ REGN 54 Stanicky 54 Tom Cholnoky 54 Mark Schoenebaum 54 Auxilium Pharma 54 Reiterates Neutral Rating 54 analyst Robert Cihra 54 analyst Vivek Juneja 54 Jason Gurda 54 George Grofik 54 analyst Amit Hazan 54 NASDAQ RDEA 54 Dificid 54 Bert Hazlett 54 NASDAQ ONXX 54 Reiterates Outperform 54 Matthew Heimermann 54 analyst Ashwin Shirvaikar 54 Inc. Nasdaq IDIX 54 Mark Monane 54 IG HCR ;) CO 54 Andrew Obin 53 midstage trials 53 Dr. Joshua Schimmer 53 Dominic Valder 53 Moussatos 53 Monane 53 economist Naoki Murakami 53 analyst Frederick Searby 53 Edward Tenthoff 53 Andy Kaplowitz 53 April Scee 53 analyst Hari Sambasivam 53 Inc. Nasdaq IMGN 53 Molowa 53 midstage clinical 53 Randall Stanicky 53 analyst Arjun Murti 53 Reiterates Hold 53 Medivation Inc 53 Gets Downgraded 53 CAMBRIDGE Mass. Biotechnology 53 William F. Tanona 53 Dendreon Provenge 53 BMY.N 53 Michael Rehaut 53 Charles Minervino 53 Phil Nalbone 53 Orexigen Contrave 53 Glenn Novarro 53 Thomas Cholnoky 53 Amylin Eli Lilly 53 Kevin Scotcher 53 economist Joachim Fels 53 drug Treanda 53 analyst Lori Appelbaum 53 AMAG Pharma 53 analyst Dara Mohsenian 52 Nasdaq IDIX 52 Cubist Pharma 52 David Hochstim 52 Celgene Revlimid 52 analyst Kota Yuzawa 52 ANALYST TAKE JP Morgan 52 analyst Joshua Shanker 52 BIIB.O Quote Profile Research 52 Folotyn 52 Gilead Sciences nasdaq GILD 52 Shire ADR Reptg 52 Ahmar Zaman 52 Tushar Poddar economist 52 COMPANIES TO WATCH 52 analyst Rick Sherlund 52 Polymeropoulos 52 analyst Liana Moussatos 52 Co BMY.N 52 Celgene NASDAQ CELG 52 analyst Stephen Tusa 52 analyst Larry Biegelsen 52 analyst Vivek Arya 52 Nasdaq OSCI 52 TSRX 52 Vertex Pharma 52 analyst Katy Huberty 52 Canvaxin 52 Larry Biegelsen 52 economist Kwon Goohoon 52 Carl Seiden 52 Regeneron Pharma 52 Pantginis 52 John DiFucci 52 PTK ZK 52 analyst Annabel Samimy 52 NASDAQ ALXN 52 initiate Phase IIb 52 experimental hepatitis C 52 economist Ryo Hino 52 ABX EGF 52 economist Ted Wieseman 52 Global Industrials Unplugged 52 PRNewswire FirstCall Idenix Pharmaceuticals 52 Inc. Nasdaq ANDS 52 Recentin 52 Thomas R. Wadewitz 52 analyst Glenn Novarro 52 developer Antisoma plc 52 Analysts Initiate Coverage 52 Alnylam Nasdaq ALNY 52 strategist Abhijit Chakrabortti 52 Joseph Pantginis 52 Submits Response 51 analyst Shebly Seyrafi 51 Reiterates Buy rating 51 SAN FP 51 analyst Robert Koort 51 Nigel Dally 51 analyst Amit Bhalla 51 Annabel Samimy 51 NASDAQ ALTH 51 Jason Kolbert 51 analyst Rommel Dionisio 51 analyst Ajit Pai 51 buy Qualitest Pharmaceuticals 51 NASDAQ IDIX 51 Affymax AFFY 51 Elizabeth Pfeuti 51 Inc. Nasdaq AFFY 51 reaffirmed Neutral 51 Forest Labs FRX 51 analyst Ehud Gelblum 51 Andreas Theisen 51 PRNewswire FirstCall Medarex 51 Maintains Hold 51 OSI Tarceva 51 Merck boceprevir 51 Ariad Pharmaceuticals 51 GILD.O Quote Profile Research 51 Rajesh Ghai 51 analyst Amit Daryanani 51 motesanib 51 Steven Alexopoulos 51 analyst Julio Quinteros 51 Two Investor Conferences 51 Seattle Genetics SGEN 51 Raises PT 51 Aegerion Pharmaceuticals Inc. 51 Resumes Coverage 51 Seamus Fernandez 51 Xgeva 51 Maintains Neutral 51 virus HCV protease inhibitor 51 Matthew Fassler 51 Rating Maintained 51 Amylin AMLN 51 Nasdaq CADX 51 analyst Jeff Fidacaro 51 analyst Darin Arita 51 Achieves Primary Endpoint 51 Spin Off Discover 51 mitoxantrone plus 51 analyst Michael Exstein 51 Richard Kwas 51 LAF# 51 Pranjul Bhandari 51 Roche Actemra 51 analyst Bruce Harting 51 NASDAQ ANDS 51 Lawrence Biegelsen 51 Ziopharm 51 analyst Kian Abouhossein 51 Holger Blum 50 Sara Michelmore 50 Assumes Coverage 50 ORAL Sync 50 Ron Bentsur 50 NASDAQ OSIP announced 50 Michael Jalonen 50 Bob Drbul 50 BioMarin Pharma 50 Vertex VRTX 50 Vertex Pharmaceuticals Inc 50 Amevive 50 Corcept Therapeutics 50 Inc. NASDAQ EVVV 50 Rachael Rothman 50 Camvia 50 Matt Miksic 50 ZGEN 50 Asset Management GSAM 50 Curagen 50 Provenge prostate cancer 50 seller antidepressant Effexor 50 AGā 50 Edward Najarian 50 analyst Nigel Dally 50 Inc. Nasdaq MITI 50 Joshua Raskin 50 Nasdaq CBST 50 Donald Fandetti 50 volatility Elevated 50 Xoma Ltd 50 Jesse Tortora 50 Justin Hott 50 Vishal Shreedhar 50 analyst Moshe Orenbuch 50 Inc. NASDAQ ALKS 50 Amgen Vectibix 50 newratings.com Analyst Jonathan Aschoff 50 analyst Margaret Mager 50 Begins Dosing 50 analyst Sal Tharani 50 Varian Semi 50 analyst Laurent Horrut 50 analyst Michael Masdea 50 exenatide LAR 50 analyst Romit Shah 50 Reiterates Sell 50 analyst Robert Drbul 50 Leerink Swan 50 Andrea Rachman 50 economist Rohini Malkani 50 Vertex hepatitis C 50 William Tanona 50 Maintains Overweight 50 PRNewswire FirstCall Micromet 50 Inc. NASDAQ VVUS 50 Corporation GENZ 50 USD #.#bln [001] 50 analyst Dorothy Lakner 50 Nasdaq NBIX 50 Sterling Auty 50 Simona Jankowski 50 analyst Alex Gauna 50 Corp. CELG 50 Maintains Buy rating 50 Douglas Harned 50 John Calcagnini 50 analyst Simona Jankowski 50 Mr. Bentsur 50 albiglutide 50 Fourth Quarter Earnings Preview 50 analyst Mark Edelstone 50 Isis Pharma 50 BioCentury NewsMakers 50 Idenix Pharmaceuticals 50 Inc. Nasdaq BIOD 50 Sherri Scribner 50 Inc. NASDAQ SUPG 50 analyst Brad Reback 50 By Sophie Mosca 50 Allan Monks 49 Biogen multiple sclerosis 49 analyst Simos Simeonidis 49 ANALYST TAKE Credit Suisse 49 analyst Adrianne Shapira 49 Vpriv 49 RAPTIVA R 49 Takehiro Sato economist 49 Andrew Kligerman 49 LSE ASM 49 analyst Charles Grom 49 OGXI 49 Corp. Nasdaq GENZ 49 NASDAQ PGNX 49 Michael Exstein 49 Jonathan Aschoff 49 Inc. Nasdaq MEDX 49 analyst Emme Kozloff 49 Co LLY.N 49 analyst Jeffrey Zekauskas 49 newratings.com Analyst Kurt Hallead 49 Amylin Byetta 49 ImClone Erbitux 49 Deane Dray 49 Jeff Kvaal 49 CE Unterberg 49 Sprycel dasatinib 49 Somatuline Depot 49 refractory acute lymphoblastic 49 Olav Zilian 49 Fanapt iloperidone 49 Krystexxa 49 analyst Betsy Graseck 49 Vertex Pharmaceuticals NASDAQ VRTX 49 TRACON Pharmaceuticals 49 Small Cap Institutional Investor 49 AstraZeneca Plc AZN.L 49 analyst Uche Orji 49 Makoto Yamashita strategist 49 Atelvia 49 NASDAQ TRBN 49 Nasdaq AMLN 49 Mabthera 49 Prempro pills 49 Glenn Reicin 49 Promacta 49 BernsteinResearch 49 economist Takuji Aida 49 Nasdaq INCY announced 49 breast cancer pill Tykerb 49 Lowers Estimates 49 Corlux 49 NASDAQ ADLR 49 RANK Ligand inhibitor 49 analyst Dinesh Moorjani 49 Zocor Merck 49 Gattex 49 analyst Yuji Fujimori 49 Millennium Velcade 49 Insmed Incorporated NASDAQ INSM 49 Global Industrials 49 Raptiva efalizumab 49 Analyst Rebecca Arbogast 49 Nasdaq MITI biopharmaceutical 49 WHATS AHEAD 49 GILD GILD 49 Itay Michaeli 49 Michael Shillaker 49 Sepracor SEPR 49 Giovanni Serio 49 Nasdaq MAXM SSE MAXM 49 Ken Zerbe 49 Groschke 49 analyst Alexia Quadrani 49 Inc. Nasdaq VVUS 49 Nasdaq IMGN 49 Jeffrey Frelick 49 Inc. Nasdaq ABGX 49 Inc. Nasdaq AMLN 49 Maintains Buy 49 analyst Jeffrey Kvaal 49 Global Healthcare Unplugged 49 NASDAQ ISTA 49 Encysive surged 49 Biogen Genentech 49 Nasdaq BIIB 49 Submits Biologics License Application 49 Sven Borho partner 49 Dendreon Corp 49 Retailing Leaders 49 analyst Moshe Katri 49 Nasdaq SLXP 49 Reiterates Buy 49 dacetuzumab collaboration 49 Steven Burakoff 49 Onyx Pharmaceuticals ONXX 49 analyst Mark Wienkes 49 analyst Maynard Um 49 Oncogenex 49 3Q Profit Doubles 49 Kochnover 49 ICSC tally 49 Adventrx 49 Raj Denhoy 49 Ricky Goldwasser 49 Bristol Myers BMY 49 Jay Deahna 49 DPP4 inhibitor 49 spokeswoman Mariann Caprino 49 macitentan 49 Bill Shope 49 Michael Turits 49 Mark Wienkes 49 Dynavax Technologies Corp 49 B. Nemeroff 49 Inc. www.micromet inc.com 49 Arzerra ofatumumab 48 ABGX 48 Sal Tharani 48 analyst William Pecoriello 48 MYL.N Quote Profile Research 48 Jon Lecroy 48 Simulcast Presentation 48 www.piperjaffray.com 48 S NOVO B.KO 48 Sol Barer 48 analyst Bijan Moazami 48 Piper Jaffray downgraded 48 Kathryn Huberty 48 Zadaxin 48 OMRIX Biopharmaceuticals 48 Pfizer inhaled insulin 48 Aaron Reames 48 Raises Estimates 48 Cumulative placements 48 Elan Tysabri 48 analyst Elizabeth Osur 48 Velcade bortezomib 48 Ken Hoexter 48 Risperidone Oral Solution 48 PRNewswire FirstCall Anadys Pharmaceuticals 48 analyst Frank Mitsch 48 Michael Leuchten 48 analyst Youssef Squali 48 Volterra Semi 48 Nasdaq DYAX 48 analyst Constance Maneaty 48 Sven Jari Stehn 48 Rigel Pharmaceuticals NASDAQ RIGL 48 Rhyee 48 Randal Konik 48 earnigns 48 Tony Clapsis 48 WALTHAM Mass. ImmunoGen 48 Douglas Anmuth 48 ThinkEquity downgraded 48 economists Takuji Okubo 48 Cervarix cervical cancer 48 Penwest Pharma 48 economist Masaaki Kanno 48 Jesse Pichel 48 Claudia Shank Hueston 48 F2Q EPS 48 Reiterates Hold Rating 48 Co BMY 48 Revlimid 48 Mahesh Sanganeria 48 Onyx Pharmaceuticals Inc 48 analyst Amir Rozwadowski 48 Celgene Corp CELG.O 48 1Q Profit Beats 48 analyst Mario Pierry 48 Ryland Presentation 48 Reddoch 48 Nasdaq VRTX 48 analyst Julian Easthope 48 Allos Therapeutics Incorporated 48 LSE AZN 48 Catalyst Biosciences 48 Harry Palmin President 48 Andrew Vaino 48 Safi Bahcall Ph.D. 48 Nasdaq ACOR 48 Nymox Pharmaceutical 48 Ann Duignan 48 James Manuso 48 Inc.ā 48 Tenthoff 48 NASDAQ ACOR 48 Nasdaq NPSP 48 humanized interleukin 6 48 midstage studies 48 analyst Doug Leggate 48 analyst Ross Muken 48 NYSE BSC PRX 48 Firdapse 48 Earnings Preview EBay 48 spokesman Tony Plohoros 48 Gerry Hennigan 48 analyst Kristine Koerber 48 Corp. NASDAQ GENZ 48 tremelimumab 48 Cladribine 48 lintuzumab SGN 48 combines Januvia 48 Jeffrey Holford 48 analyst Shinichi Ina 48 NV1FGF 48 NASDAQ ARIA 48 analyst Elemer Piros 48 analyst Mark Lipacis 48 Gary Lapidus 48 Co. LLY.N 48 analyst Michael Bruynesteyn 48 muscle relaxant Amrix 48 please visit http:/www.atherogenics.com 48 impotence pill Cialis 48 Somatuline Autogel 48 Standpoint Research downgraded 48 analyst Michael Rehaut 48 analyst Glenn Reicin 48 drug figitumumab 48 Xenoport Inc. 48 Todd Bault 48 Betsy Van Hees 48 Carla Antunes da Silva 48 generation Taxus Liberte 48 GlaxoSmithKline Plc GSK LN 48 JP Morgan SMid Cap 48 phase IIb trial 48 Inc. NASDAQ IDIX 48 analyst Shaul Eyal 48 Nasdaq ALKS 48 Co. LLY.N Quote Profile 48 Ronny Gal 48 Sanofi NYSE SNY 48 Inc. NASDAQ AMGN 48 novel synthetic PEGylated 48 Kalpesh Kapadia 48 Inc. NASDAQ SGEN 48 Meredith Adler 48 Katy Huberty 48 Inc. Nasdaq KERX 48 Thomas V. Cholnoky 48 Nasdaq RGEN 48 analyst Patrick Walravens 48 Inc. Nasdaq ARNA 47 analyst Heather Bellini 47 Repros Therapeutics Inc 47 Promus Element 47 Benlysta belimumab 47 Joe Osha 47 GS.N 行情 47 analyst Junaid Husain 47 nasdaq IMCL news 47 Thoratec Presentation 47 Nasdaq BMRN 47 Timothy Arcuri 47 analyst Charles Boorady 47 Oporia 47 Corporation GENZ GENZ 47 Stacy Rasgon 47 Julian Callow economist 47 Christopher Danely 47 L. Enns 47 Forest Laboratories FRX 47 analyst Tim Klasell 47 Therapeutic Competitors companiesandmarkets.com adEgemonye 47 Inc. Nasdaq ONXX 47 Christine Farkas 47 Cubist Pharmaceuticals Inc 47 Inc. NASDAQ HGSI 47 Genentech Herceptin 47 Inc. DNA.N 47 Analyst Andrew Zarnett 47 Mark Lipacis 47 analyst Mehdi Hosseini 47 Humira adalimumab 47 BIO InvestorForum 47 Medivation MDVN 47 Amgen denosumab 47 CNVX 47 Inc. NASDAQ NBIX 47 Frazer Penn. based 47 analyst Robyn Karnauskas 47 Bayer Nexavar 47 analyst Albert Savastano 47 Alkermes ALKS 47 Joshua Shanker 47 Adrianne Shapira 47 Encore Bancshares Inc 47 Nasdaq ITMN 47 Luke Folta 47 Inc. Nasdaq TELK 47 Avastin Herceptin 47 Charles Boorady 47 Novartis Galvus 47 bln Sfr 47 Lilly Cymbalta 47 Galvus 47 analyst Randal Konik 47 Susan Katzke 47 analyst Anthony Noto 47 Sutent sunitinib malate 47 NASDAQ IPXL 47 analyst Kurt Hallead 47 analyst Kathryn Huberty 47 Analyst Bill Pecoriello 47 Berg BioMarin Pharmaceutical 47 BioCentury Future Leaders 47 ® darbepoetin alfa 47 Reuters Generic drugmaker 47 analyst Douglas Anmuth 47 Daniel Volberg 47 analyst Dean Gianoukos 47 Damien Conover 47 Kenji Masuzoe 47 Xenoport 47 economist Sun Mingchun 47 Crucell NV NASDAQ CRXL 47 reaffirmed Market Perform 47 Acorda Therapeutics Nasdaq ACOR 47 Phase Ib IIa 47 Birgit Kulhoff 47 TAXUS Element Stent System 47 Telik logo TELINTRA 47 Maintains Neutral Rating 47 generic Lovenox 47 Jeremy Sigee 47 ONXX 47 analyst Vijay Jayant 47 Ixempra 47 Nasdaq ANDS announced 47 NASDAQ INFI 47 UCB Keppra 47 Antegren 47 Inc. Nasdaq SVNT 47 Roche Holding AG RHHBY 47 John Kartsonas 47 Savient Pharmaceuticals Inc 47 analyst Natasha Boyden 47 UBS Warburg LLC 47 NASDAQ IMCL 47 strategist Adrian Mowat 47 Eyetech Pharmaceuticals 47 Craig Siegenthaler 47 comparing alemtuzumab 47 marketperform rating 47 analyst Eileen Furukawa 47 Novartis Prexige 47 newratings.com Analyst Dan Geiman 47 Fusilev 47 Christopher Horvers 47 James Covello 47 RBC Capital NYSE RY 47 CDO write downs 47 John F. Thero 47 Zocor Zetia 47 Canaccord Genuity Maintains Hold 47 Syncria 47 analyst Chad Friess 47 sees FY# EPS 47 Rick Sherlund 47 GlaxoSmithKline Tykerb 47 ThinkEquity LLC 47 Bruce Nudell 47 Optimer Pharmaceuticals 47 Joseph Foresi 47 Maintains Outperform 47 PRNewswire Anthera Pharmaceuticals 47 exenatide Byetta 47 Enoch Fung 47 Robert Lacoursiere 47 Sarah Friar 47 analyst Rob Rutschow 47 spokeswoman Lenore Gelb 47 Grofik 47 Preos 47 Nan Shan Taiwanese 47 Dealmaking Profile 47 Virginia Genereux 47 HealthCor 47 Michael Linenberg 47 NASDAQ TRCA 47 Vitaxin 47 analyst Raj Denhoy 47 analyst Jon Bergtheil 47 analyst Walter Piecyk 47 Schoenebaum 47 economist Elga Bartsch 47 compound KOS 47 Inc. NASDAQ ACOR 46 Effexor antidepressant 46 Boosts Estimates 46 lenalidomide Revlimid 46 Flamel Technologies Nasdaq FLML 46 OPTR 46 Drugmaker Merck 46 economist Chetan Ahya 46 NSABP C 46 Co. MRK.N 46 Transkaryotic Therapies TKTX 46 Jeff Klinefelter 46 strategist Teun Draaisma 46 Inc AMGN AMGN 46 Crestor statin 46 Simos Simeonidis 46 Inc. Nasdaq REGN 46 Michael Bruynesteyn 46 PiperJaffray analyst 46 NASDAQ PRXL 46 Aryx Therapeutics 46 Nasdaq NPSP announced 46 Analyst Ben Reitzes 46 Enzon Pharmaceuticals Inc 46 Carl Christensen XPRESSTRADE 46 Corp. GENZ.O Quote 46 Francesco Garzarelli 46 Navigant Consulting Inc 46 analyst Joanne Wuensch 46 Serono SRA 46 AG NOVN.VX 46 Cubist Pharmaceuticals NASDAQ CBST 46 Biomarin 46 Namenda Memantine HCl 46 evaluating tivozanib 46 Michael Huttner conservatively 46 Orencia 46 Tanona 46 Brent Thill 46 analyst Sterling Auty 46 Ziopharm Oncology 46 analyst Hussein Allidina 46 Femara letrozole 46 NASDAQ APPA specialty 46 analyst Kimberly Greenberger 46 solanezumab 46 economist Kyohei Morita 46 Co BMY.N Quote Profile 46 Neibor 46 Quynh Pham 46 Nasdaq GPRO announced 46 Satya Chillara 46 Biegelsen 46 NASDAQ GNTA 46 analyst Hisashi Moriyama 46 Roche Mircera 46 Darren Lehrich 46 Nicox 46 Simponi golimumab 46 Fablyn 46 analyst Masahiro Ono 46 analyst Ben Reitzes 46 Matt Nemer 46 Teva Pharmaceutical NASDAQ TEVA 46 AG NVS 46 analyst Mahesh Sanganeria 46 analyst Jason Gurda 46 Switzerland Serono SA 46 Oxigene 46 NASDAQ PCYC 46 Nasdaq CRDC 46 Cantor Fitzgerald reiterates 46 Paliperidone Palmitate 46 RBC Capital Mkts Reiterate 46 Byetta LAR 46 Hovnanian Enterprises Presentation 46 Ironwood Pharmaceuticals Inc. 46 Gary Nachman 46 Kaufman Bros reiterate 46 Frederick Searby 46 GlaxoSmithKline GSK.L 行情 46 analyst Ann Duignan 46 analyst Laura Champine 46 Dahlman Rose downgraded 46 Eric Selle 46 RESEARCH ALERT Citigroup 46 Lori Appelbaum 46 SHP LN 46 analyst Jeffrey Fidacaro 46 Excedrin Plavix 46 Dorothy Lakner 46 Keeps Neutral 46 Deborah L. Weinswig 46 JMP Securities downgraded 46 analyst Laura Conigliaro 46 William Pecoriello 46 analyst Gregory Melich 46 Nasdaq KOSP 46 Neil Flanzraich 46 azilsartan medoxomil 46 PRNewswire FirstCall InterMune 46 Estimates Boosted 46 Michael Masdea 46 By Rachel Rossitto 46 Vance Edelson 46 lowers FY# EPS 46 Jon LeCroy 46 Cai von Rumohr 46 analyst Ikuo Matsuhashi 46 economist Hiroshi Shiraishi 46 pneumonia vaccine Prevnar 46 Kulbinder Garcha 46 Nuedexta 46 Nick Bertolotti 46 Impax Laboratories IPXL 46 ZALBIN 46 NYSE Amex PTN 46 NASDAQ NPSP 46 NASDAQ RGEN 46 strategist Makoto Yamashita 46 Inspire Pharmaceuticals Inc 46 Joe Pantginis 46 Novartis AG NOVN VX 46 uh ruh 46 BIIB Short Term 46 Amylin Pharmaceuticals Inc 46 CombinatoRx Incorporated NASDAQ CRXX 46 analyst Pablo Zuanic 46 Third Quarter Loss Widens 46 drugmakers Eli Lilly 46 CIMZIA r 46 FBR Capital NASDAQ FBCM 46 Humira rheumatoid arthritis 46 Mingchun Sun 46 Co. MER 46 spokeswoman Rohini Pragasam 46 testosterone gel LibiGel 46 SAN DIEGO Ligand Pharmaceuticals 46 analyst Hamed Khorsand 46 economist George Tharenou 46 analyst Peter Nesvold 46 Lauren Cooks Levitan 46 anticlotting medicine 46 Flector Patch 46 Drugmakers AstraZeneca 46 Abbott Niaspan 46 Novo Nordisk NOVOb.CO 46 Analysts Upgrades Downgrades 46 denosumab 46 Arcalyst 46 inhalable insulin product 46 Minggao Shen 46 alogliptin 46 Achillion Pharmaceuticals 46 Farooq Hanif 46 QLT CN 46 Company Nasdaq PRGO 46 Maintains Hold Rating 46 Victoza liraglutide 46 Kash Rangan 46 Wyeth WYE.N 行情 46 Daniel Meron 46 Sanjiv Wadhwani 46 CAMPATH 46 NOVN.VX Quote Profile Research 46 mesylate tablets 46 John Herrlin 46 Pegintron 46 Alexia Quadrani 46 Helen Qiao economists 46 Mark Liinamaa 46 Wedbush Maintains 46 Ajit Pai 46 Therapeutic Competitors 46 adalimumab Humira 46 Doug Sipkin 46 analyst Katherine Styponias 46 Cantor Fitzgerald reiterate 46 Yervoy 46 Srini Pajjuri 46 Mamoru Yamazaki 46 analyst Ananda Baruah 46 Oppenheimer NYSE OPY 46 Georges Gemayel 46 NASDAQ CLDX 46 Sanofi Aventi 46 Isaac Ro 46 Hamed Khorsand 46 pills Januvia 46 Rohini Pragasam spokeswoman 46 Andrew Goodsall 46 Co. nyse LLY 46 analyst Andrew Obin 45 NASDAQ VRUS 45 Nasdaq ISTA 45 analyst Deane Dray 45 Inc. Nasdaq ARQL 45 Aldo Mazzaferro 45 Natasha Boyden 45 Jerry Doctrow 45 analyst Edwin Mok 45 Trevor Polischuk 45 Friedman Billings reiterate 45 Neutral Weight 45 Abhijit Chakrabortti 45 Ethyol 45 Eloxatin oxaliplatin 45 Tal Liani 45 Lawrence Keusch 45 Xiaflex 45 Dr. Laikind 45 Third Quarter Earnings Preview 45 Bruce Harting 45 Galida 45 Teva Copaxone 45 Egrifta 45 PRNewswire FirstCall Amylin Pharmaceuticals 45 economist Drew Matus 45 UKâ 45 analyst Jacques Rousseau 45 s crizotinib ZAH 45 Savvas Neophytou 45 Range Tightening 45 ANALYST TAKE Goldman Sachs 45 Nasdaq IDRA 45 FBR Capital Upgrades 45 analyst Allan Mishan 45 J. Steven Smigie 45 Plovanic 45 analyst Matthew Fassler 45 Cannacord Adams 45 F#Q# EPS ahead 45 George Toriola 45 Quadrani 45 Bristol Myers NYSE BMY 45 Jon Kamp 45 Rating Reiterated 45 Maintains Sell 45 Nasdaq EXAS today 45 SGP.N Quote Profile Research 45 @ FiercePharma 45 CARMIEL Israel 45 Drew Matus economist 45 Shire Plc SHP.L 45 Tesofensine 45 Healthcare Tailwinds Conference 45 Joseph Greff 45 Steven Winoker 45 Satoru Ogasawara strategist 45 ANALYST TAKE Merrill Lynch 45 please visit http:/www.vandapharma.com 45 Merck KGaA MRK GY 45 Idenix Pharmaceuticals Inc 45 lasofoxifene 45 Analyst Toni Sacconaghi 45 Shari Schwartzman Eberts 45 IG IGS ;) CO 45 PRNewswire FirstCall AEterna Zentaris 45 analyst Gregory Badishkanian 45 Zidovudine Tablets 45 Ralph Giacobbe 45 Nasdaq HALO 45 Taranabant 45 Mark Edelstone 45 Helene Wolk 45 cetuximab Erbitux 45 markets Testim ® 45 Simeonidis 45 MyVax 45 Colazal 45 AG DB DBK.XE 45 BAS ML 45 WHAT 'S EXPECTED 45 Inc. NASDAQ ACUS 45 AstraZeneca Plc AZN LN 45 Y. Edwin Mok 45 Rupak Ghose 45 ocrelizumab 45 Protalix BioTherapeutics Inc 45 oral mesalamine 45 NYSE PFE Exelon Rivastigmine 45 Piper Jaffray Reiterates 45 spokeswoman Tatjana Domke 45 FY# revs 45 Citi Initiates Coverage 45 Xenical prescription 45 Lexapro Effexor Serzone